John R. Fulghum

机构：Vertex Pharmaceuticals (United States)

发表论文 15 篇 · 总被引 1000 次 · h-index 11

代表论文

• In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061 (2004 · Journal of Biological Chemistry · 被引 288)
• In Vitro Studies of Cross-resistance Mutations against Two Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061 (2005 · Journal of Biological Chemistry · 被引 216)
• Structure of Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinase 2 Suggests a Bifunctional Switch That Couples Kinase Activation with Nuclear Export (2002 · Journal of Biological Chemistry · 被引 132)
• High-throughput screening for soluble recombinant expressed kinases in Escherichia coli and insect cells (2004 · Protein Expression and Purification · 被引 74)
• Biochemical Analysis of the Modular Enzyme Inosine 5′-Monophosphate Dehydrogenase (1999 · Protein Expression and Purification · 被引 59)
• Screening factors effecting a response in soluble protein expression: Formalized approach using design of experiments (2005 · Analytical Biochemistry · 被引 58)